Objective To examine differences in health care charges following a pediatric epilepsy diagnosis based on changes in health-related quality of life (HRQOL). Methods Billing records were obtained for 171 youth [M (SD) age ¼ 8.9 (4.1) years] newly diagnosed with epilepsy. Differences in health care charges among HRQOL groups (stable low, declining, improving, or stable high as determined by PedsQL TM scores at diagnosis and 12 months after diagnosis) were examined. Results Patients with persistently low or declining HRQOL incurred higher total health care charges in the year following diagnosis (g ¼ .49, g ¼ .81) than patients with stable high HRQOL after controlling for epilepsy etiology, seizure occurrence, and insurance type. These relationships remained consistent after excluding health care charges for behavioral medicine or neuropsychology services (g ¼ .49, g ¼ .80).
Epilepsy is a chronic neurological disorder that affects 1% of youth in the United States (Russ, Larson, & Halfon, 2012) . A diagnosis of epilepsy requires at least two unprovoked seizures in a 12-month period, and treatment typically includes diagnostic procedures (i.e., electroencephalography [EEG] , magnetic resonance imaging [MRI] ), antiepileptic drugs (AEDs), routine blood draws, follow-up clinic appointments, and implementation of safety guidelines (e.g., revoked driving privileges). The principal goal of this comprehensive approach is to enable patients to achieve seizure control with no adverse side effects while optimizing quality of life (Guilfoyle, Wagner, Smith, & Modi, 2012) .
The cost of routine medical care for youth with epilepsy to achieve these goals is substantial, particularly in the first year following diagnosis (Beghi, Frigeni, Beghi, De Compadri, & Garattini, 2005; Begley et al., 2000) . Yearly expenditures for pediatric epilepsy treatment range from $522 to $9,713 per patient and are primarily driven by costs associated with AEDs, follow-up clinic visits, and diagnostic procedures (Cramer et al., 2014; Salih et al., 2012) . For the 20-40% of youth with epilepsy who do not achieve seizure control following trials of two AEDs, more invasive and expensive treatment options, such as device implantation (e.g., vagus nerve stimulator) or brain surgery may be needed (Wilby et al., 2005) . Thus, it is not surprising that variability in health care costs has been associated with several disease-related factors, including epilepsy severity, seizure activity, and AED side effects (Begley, Lairson, Reynolds, & Coan, 2001; Cramer et al., 2014) . The cost of epilepsy care for youth with poorly controlled epilepsy is nearly double that of routine epilepsy care for patients with controlled epilepsy, with the majority of excess costs resulting from hospitalizations and emergency department (ED) visits (Beghi et al., 2005) . While helping patients achieve seizure freedom is certainly one way to reduce avoidable health care charges in pediatric epilepsy, there may be other factors to consider for cost reduction.
Researchers have investigated modifiable correlates of health care costs in pediatric and adult populations (e.g., Eisner et al., 2002; Ryan et al., 2013; Simon-Tuval et al., 2011) , including youth newly diagnosed with epilepsy. Results of a recent study of 258 youth with epilepsy found that poorer health-related quality of life (HRQOL) early in the treatment process predicted increased health care charges in the year following diagnosis, after controlling for key demographic (e.g., insurance status) and clinical (e.g., epilepsy type, seizure occurrence since diagnosis, and AED side effects) factors (Ryan et al., 2015) . These findings are consistent with a body of literature demonstrating that factors beyond and independent of seizures or side effects (e.g., perceived stigma, academic underachievement, parental anxiety, and family stress) may also influence pediatric HRQOL (Ferro, 2014; Jackson et al., 2013; Wu, Follansbee-Junger, Rausch, & Modi, 2014) . Thus, efforts targeting HRQOL and well-established disease factors (e.g., seizures) may each independently enhance current cost savings efforts and reduce unnecessary/excessive health care use.
One limitation of this prior study was that HRQOL was assessed following the epilepsy diagnosis, making it difficult to differentiate impairments associated with adjustment to the epilepsy diagnosis and disease factors (i.e., AED side effects) versus those reflective of the child's baseline level of functioning. There is a growing body of literature suggesting that impairments across several domains of functioning (i.e., internalizing/externalizing symptoms, academic underachievement, family conflict, and parental depression) might predate the onset of epilepsy and persist despite achieving seizure control (Hesdorffer, 2013; Oostrom et al., 2003) . Thus, youth presenting with poorer HRQOL at diagnosis and before treatment initiation may be more vulnerable to the potential adverse effects of epilepsy treatment (i.e., AED side effects, physical limitations), and in turn, at increased risk for excessive health care use and higher costs. Youth who experience continued seizure activity or side effects after starting treatment, in the absence of premorbid impairments at diagnosis, may also incur substantial health care costs. The longitudinal HRQOL course (e.g., stable low, declining, improving, and stable high HRQOL) may be used to determine the differential impact of HRQOL at diagnosis and follow-up on health care charges in the year following diagnosis among youth with epilepsy.
In light of the health care system's increased emphasis on cost containment, identifying patients at risk for incurring disproportionately higher health care charges is critical to informing the appropriate allocation of resources. Specifically, differences in health care charges among youth with epilepsy as a function of longitudinal HRQOL course might provide further support for the up-front investment in behavioral medicine services that target HRQOL and have the potential to prevent future excessive health care charges (Rozensky & Janicke, 2012) .
This study aimed to examine differences in health care charges in the 12 months following diagnosis among youth with epilepsy based on the longitudinal HRQOL course during this period. To begin to inform hypotheses about potential group differences in health care charges, the secondary aim of this study was to describe the types of medical encounters comprising health care charges for each group. Youth with epilepsy exhibiting poor HRQOL at diagnosis and/or follow-up were hypothesized to incur higher health care charges in the year following epilepsy diagnosis than youth who exhibited stable high or improved HRQOL from diagnosis to follow-up. Consistent with previous research (Beghi et al., 2005) , it was hypothesized that differences between these groups would be attributable to higher health care charges for ED visits and hospitalizations.
Methods
All data for this study were extracted as part of a larger retrospective chart review project (Guilfoyle, Follansbee-Junger, & Modi, 2013) approved by the hospital's institutional review board.
New Onset Seizure Clinic and Patient Population
Patients included in the current study were diagnosed with epilepsy between July 2011 and December 2012 and received treatment in the New Onset Seizure (NOS) Clinic within a comprehensive epilepsy center at a large pediatric hospital in the Midwestern United States. Interdisciplinary care at this clinic involves epileptologists, specialist nurse practitioners, psychologists, pharmacists, social workers, and nurses working collectively to maximize the likelihood that recently diagnosed youth will reach the three primary goals of epilepsy treatment (i.e., no seizures, no AED side effects, best HRQOL). The NOS Clinic treats children between 2 and 18 years of age who are newly diagnosed with epilepsy and expected to respond positively to AED treatment. Patients presenting with (a) another significant medical disorder (e.g., diabetes, brain tumor), (b) a significant psychological disorder (e.g., bipolar disorder) or developmental delay (e.g., autism), (c) previous AED prescriptions, or (d) requests for a second opinion are referred to a general neurologist.
A total of 258 patients meeting the aforementioned criteria were included in the larger cohort for the retrospective chart review project (Ryan et al., 2015) . The purpose of this manuscript was to examine the relationship between health care charges and longitudinal HRQOL course from baseline to 9-12 months postdiagnosis. The 9-12-month timeframe is a clinically relevant period for assessing HRQOL as patients are less likely to have acute side effects, are typically on a stable AED regimen, response to AEDs become clearer, and the acute adjustment to diagnosis has typically passed. Thus, consistent with the aims of the current study, patients who did not return to NOS Clinic in the 9-12 months following diagnosis (n ¼ 75) were excluded from the larger sample, yielding an analysis sample of N ¼ 183.
Standard of Care
At treatment initiation, patients experiencing undiagnosed seizures undergo a diagnostic assessment with an epileptologist including an EEG and MRI. Patients subsequently diagnosed with epilepsy (i.e., two unprovoked seizures in a 12-month period) are typically prescribed an AED and then asked to return for outpatient epilepsy clinic visits with a specialist nurse practitioner 1 month postdiagnosis and every 3 months thereafter. Patients are recommended to complete a behavioral medicine consultation with a licensed clinical psychologist during at least two epilepsy clinic visits each year. Patients at higher psychosocial risk are recommended to complete more frequent behavioral medicine consultations. Behavioral medicine consultations typically include routine assessments of patient psychosocial functioning; brief, targeted interventions to improve HRQOL among patients reporting poor psychosocial functioning; and referrals for outpatient therapy and neuropsychological evaluation as necessary.
Measures and Procedures
HRQOL: Pediatric Quality of Life Inventory, Version 4.0 The Pediatric Quality of Life Inventory, Version 4.0 (PedsQL TM 4.0) is a 23-item parent-report measure designed to assess generic HRQOL among children between 2 and 18 years of age (Varni, Seid, & Kurtin, 2001) . Parents rate impairments in HRQOL across four domains of functioning: Physical (eight items), Emotional (five items), Social (five items), and School (five items), using a 5-point Likert scale (0 ¼ never a problem, 4 ¼ almost always a problem). An overall estimate of HRQOL is obtained by computing a mean of all completed items. Scores range from 0 to 100, with higher scores representing better HRQOL. The PedsQL TM has excellent internal reliability (e.g., rs ¼ 0.89-0.93; Varni, Limbers, & Burwinkle, 2007) , including parent proxy-reported HRQOL as an estimate of child functioning (Haneef et al., 2010 Varni et al., 2001 ) was used to dichotomize baseline and follow-up PedsQL TM scores for the current sample. Scores were dichotomized according to previous research demonstrating that PedsQL TM total scores less than 75.28, or more than 1 SD below the population sample mean (87.61 À 12.33 ¼ 75.28), represent "at-risk" status (Schimmer, Burwinkle, & Varni, 2003; Varni, Burwinkle, Seid, & Skarr, 2003) . Thus, for the purposes of this manuscript, PedsQL TM total scores < 75.28 (more than 1 SD below the population sample mean) were classified as "low." Total scores ! 75.28 were classified as "high." Second, patients were classified into one of four groups based on their PedsQL TM dichotomous classifications: (1) stable low (low-low); (2) declining (high-low); (3) improving (low-high); or (4) stable high (high-high).
Health Care Charges and Medical Encounters
Hospital and physician billing records detailing the charges of all medical encounters in the year following epilepsy diagnosis were obtained from the institution's accounting database. These data included charges related to ambulatory care, hospitalizations, ED visits, laboratory tests, and diagnostic procedures but did not reflect insurance reimbursement, co-pays, or premiums. As encounters outside of the Neurology Department may be indirectly related to the patient's epilepsy diagnosis (e.g., neuropsychological testing owing to possible learning disorder or attention deficit hyperactivity disorder), all medical charges were extracted. Charge data spanning multiple years were adjusted to 2014 U.S. dollars according to the medical care component of the Consumer Price Index (U.S. Bureau of Labor Statistics, 2014) to account for inflation and allow for comparisons across patients receiving medical care at different time points. To convert each health care charge to base year 2014 dollars, the price index for April 2014 (i.e., $434.05) was divided by the price index for each data year (e.g., $414.92 in 2012) and then multiplied by the charge for that year. For example, a 2012 charge of $1,000 would be $1,046 in 2014.
Charges were summed at the encounter level for each patient. Encounters were then classified as an outpatient clinic visit, hospital admission, ED visit, laboratory test, or diagnostic procedure according to our previously published criteria (see online supplement). Using these criteria, outpatient clinic visits were further classified as those for behavioral medicine, neurology, neurosurgery, or another discipline and hospitalizations, and ED visits were classified as epilepsy-related or non-epilepsy-related. Two authors independently reviewed the classification of 20% of patient medical encounters (initial agreement ¼ 99%). Discrepancies were resolved by discussion between the first two authors.
Demographic and Clinical Variables
Three trained research assistants completed retrospective chart reviews to collect demographic, clinical, and psychosocial variables (i.e., patient age at diagnosis, sex, insurance status, date of epilepsy diagnosis, epilepsy etiology, prescribed AED at diagnosis, seizure occurrence postdiagnosis, and PedsQL TM scores) for all patients. Seizure occurrence postdiagnosis was defined as the presence of one or more seizures in the 12 months following diagnosis. A dichotomous, rather than a count variable, was used as the heterogeneity of seizure types (e.g., absence seizure vs. generalized tonic-clonic seizure) and whether someone was present to witness the seizure can compromise the accuracy of seizure reports by parents (Akman et al., 2009) . Moreover, even a single unprovoked seizure is associated with increased health care charges (Begley et al., 2001 ) and decreased HRQOL (Modi et al., 2009 ).
Statistical Analyses
Before conducting primary study analyses, patterns of missing data were explored. Multiple imputation was used to account for missing data, but attempting to impute missing PedsQL TM scores resulted in different imputed values for the missing data, and participants were classified into different IV groups across the imputed data sets based on different imputed PedsQL TM score values. This resulted in unequal numbers of patients within each of the independent variable (IV) groups across the imputed data sets. As multiplegroup analyses require equivalent numbers of participants in all HRQOL groups across all imputed data sets, missing values could not be imputed. Thus, patients with missing parent-proxy PedsQL TM scores at baseline (n ¼ 7) or 9-12 months postdiagnosis (n ¼ 5) were excluded from the analyses, resulting in a final sample size of N ¼ 171. Descriptive statistics were then calculated for each medical encounter type and within each HRQOL group.
Differences in health care charges were evaluated using multigroup structural equation modeling (SEM). Multigroup SEM analyses allow for estimating differences between multiple response variables known to have nonzero correlations, and thus permits analysis of the variation in health care charges across HRQOL groups while controlling for the influences of multiple covariates (Kline, 2011) . Model 1 was used to examine differences in total health care charges across the four HRQOL groups and included the following covariates: epilepsy etiology, presence of a seizure since diagnosis, and insurance type. Using the same predictor (HRQOL group) and covariates as in Model 1, Models 2 and 3 were used to examine differences in health care charges excluding psychological services (e.g., behavioral medicine and neuropsychological testing) (Model 2) and health care charges for epilepsy-related hospital admissions (Model 3). Group differences in charges for epilepsy-related ED visits were not examined because patients with improving HRQOL incurred no such charges (i.e., an independent variable group showed a response variable variance near zero).
As SEM can be substantially affected by sample size, estimates of effect size and 95% confidence intervals were reported in addition to significance test results. Standardized mean differences (Hedges' g to correct for positive bias in the pooled standard deviation, Durlak, 2009 ) between HRQOL groups were calculated using model-reproduced means and standard deviations accounting for covariate effects. Model estimates were not available for epilepsyrelated ED visits; Hedges' g's representing differences between HRQOL groups in epilepsy-related ED visits were calculated using observed sample data means and standard deviations (RCoreTeam, 2013) .
Results
The final sample included 171 children and adolescents (M age ¼ 8.90 years, SD ¼ 4.10) newly diagnosed with epilepsy (Table I ). Approximately half of all patients were females (n ¼ 84, 49%) and the majority of patients were Caucasian (n ¼ 146, 85%). Over two-thirds of patients carried private insurance (n ¼ 116, 68%). Consistent with the population of patients served by the NOS clinic, the majority of patients were diagnosed with idiopathic epilepsy (n ¼ 140, 82%) and roughly equal numbers of patients were diagnosed with localization-related (n ¼ 67, 39%) and generalized (n ¼ 64, 37%) epilepsy. Nearly all patients were prescribed an AED at diagnosis (n ¼ 165, 96%) and two-thirds of patients experienced at least one seizure in the year following diagnosis (n ¼ 113, 66%).
The majority of patients reported relatively stable HRQOL course (Table II) , with almost 60% (n ¼ 102; stable high) endorsing high HRQOL at baseline and follow-up and 20% (n ¼ 34; stable low) endorsing low HRQOL at baseline and follow-up. Of the 20% of patients reporting changing HRQOL in the 12 months following diagnosis, 11% (n ¼ 19; declining) decreased from high to low and 9% (n ¼ 16; improving) increased from low to high.
Total Health Care Charges
Means and standard deviations for health care charges by HRQOL group are outlined in Table III. Table IV includes results of structural equation models examining group differences in health care charges and corresponding effect size estimates. All analysis models were fully saturated with zero degrees of freedom, meaning all fit indices were at their ideal values (i.e., comparative fit index ¼ 1, root mean square error of approximation ¼ 0). 
Epilepsy-Related Hospitalizations
Over a quarter (26%, n ¼ 5) of patients with declining HRQOL had at least one epilepsy-related hospital admission, compared with 21% (n ¼ 7), 12% (n ¼ 2), and 11% (n ¼ 11) of patients in the stable low, improving, and stable high groups, respectively. Patients in the declining HRQOL group incurred higher charges for epilepsy-related hospital admissions (M ¼ $19,021.66, SD ¼ $49,930.11) than patients in the stable high HRQOL group (M ¼ $2,888.49, SD ¼ $9,877.12, g ¼ .75, 95% CI: 0.25-1.25). There were no other significant differences between HRQOL groups in health care charges for epilepsy-related hospitalizations. Note. HRQOL ¼ health-related quality of life; ED ¼ emergency department. All health care charges were adjusted to April 2014 US$. Note. CI ¼ confidence interval; ED ¼ emergency department; HRQOL ¼ health-related quality of life. a Hedges' g calculated using observed sample data means and standard deviations. -¼ paths were unable to be estimated as n ¼ 0 in one group (Improving HRQOL). Bold indicates Hedge's g values with 95% confidence intervals that do not include zero.
Epilepsy-Related ED Visits
Fifty percent of ED visits were by patients in the stable low or declining HRQOL groups. Notably, 24% (n ¼ 8) of patients in the stable low group and 32% (n ¼ 6) of patients in the declining group had at least one epilepsy-related ED visit, while rates were lower for the stable high (13%, n ¼ 13) and improving (0%, n ¼ 0) groups. Patients in the declining HRQOL group incurred significantly higher charges for epilepsy-related ED visits (M ¼ $896.30, SD ¼ $1,749.25) than patients in the improving HRQOL group (M ¼ $0.00, SD ¼ $0.00, g ¼ .69, 95% CI: 0.01-1.38). There were no other significant differences between HRQOL groups in health care charges for epilepsy-related ED visits.
Other Medical Encounters
Health care charges by outpatient clinic visit type and psychology visit type are presented in Figure 1 . 
Discussion
In this sample of youth newly diagnosed with epilepsy, changes in HRQOL in the year following diagnosis predicted health care charges during the same period. Specifically, patients with persistently low or declining HRQOL following diagnosis incurred significantly higher health care charges than patients with persistently high HRQOL even after controlling for epilepsy etiology, seizure occurrence, and insurance type. These relationships remained consistent after excluding health care charges for behavioral medicine or neuropsychology services, suggesting that the between-group differences are not likely attributed to increased provision of psychological services to target low HRQOL. This finding is encouraging for pediatric psychologists and supports the current model for implementing behavioral medicine services into standard medical care for epilepsy (Guilfoyle, Follansbee-Junger, & Modi, 2013) in which HRQOL is tracked and used to inform treatment decisions (i.e., delivery of brief interventions for various emotional and behavioral problems, referrals for more intensive psychological intervention as warranted). Note. Example medical services not related to epilepsy categorized as "Other": Outpatient clinic (endocrinology, occupational therapy); Behavioral medicine (outpatient treatment for anxiety or disruptive behavior).
Differences in total health care charges between patients with declining and stable high HRQOL may be explained, in part, by the higher health care charges for epilepsy-related hospital admissions incurred by patients with declining HRQOL. Consistent with this hypothesis, compared with patients with stable high HRQOL, a relatively large number of patients with declining HRQOL were hospitalized for epilepsyrelated concerns (5/19 vs. 11/102). However, contrary to our hypotheses, patients with persistently low HRQOL did not incur higher health care charges for epilepsy-related ED visits or hospitalizations compared with patients with stable high HRQOL. Descriptive statistics suggest that patients with persistently low HRQOL incur the highest charges for nonepilepsy-related outpatient visits. Thus, it is possible that the increased charges incurred by patients with persistently low HRQOL may be attributable to higher rates of patient and/or parent comorbidities that require access to additional health care than patients in the other HRQOL groups.
It is also important to note that patients with improving HRQOL incurred relatively higher total health care charges compared with patients with stable HRQOL in the year following epilepsy diagnosis. Based on our previous findings that poorer HRQOL early in the disease process is associated with increased health care charges in the year following diagnosis (Ryan et al., 2015) , patients and families may have exhausted a number of resources until they perceived noticeable improvements in important areas of functioning. Given the broad physical and psychosocial impact of pediatric new onset epilepsy, there are likely individual differences in the factor(s) driving HRQOL and subsequent health care use. Thus, an important next step is to identify which factor, or combination of factors, are associated with both improvements and declines in HRQOL, and how they impact the frequency and type of health care use over time.
Overall, current study results and the larger literature indicate that there are two strong predictors of health care charges in youth with newly diagnosed epilepsy: seizure status and HRQOL (Begley et al., 2001; Cramer et al., 2014; Ryan et al., 2013) . Our findings extend prior literature by demonstrating that the course of HRQOL over the first year of epilepsy predicts health care charges above and beyond seizure control. This is important because 1 year following diagnosis, the acute adjustment period and side effects have passed and response to treatment is clearer (e.g., failure or success with AEDs) such that HRQOL is more reflective of overall functioning, not just the impact of disease factors.
Improvements in patient outcomes and reductions in the cost of epilepsy care may be realized by addressing not only disease factors (i.e., side effects), but also other independent predictors of poor or declining HRQOL including medical and psychosocial factors (e.g., maternal anxiety and comorbidities). For example, parental anxiety has a strong influence on HRQOL (Ferro, 2014) but is rarely addressed in pediatric epilepsy care. These findings suggest that if integrating behavioral assessments and interventions (e.g., promoting coping by encouraging parents to become involved in epilepsyspecific support groups or foundations) into clinical care enhance the parent's mental health and in turn improve the child's HRQOL, such efforts may ultimately lead to reduced health care costs.
While this paper is one of the first to examine health care charges in youth with epilepsy based on changes in HRQOL over time, several limitations are noted with consequent directions for future research. First, future research is needed to test the aforementioned hypothesized drivers of HRQOL group differences in health care charges. Specifically, longitudinal research is necessary to identify the impact of routine psychological services in pediatric epilepsy care on HRQOL and health care use. Second, the health care charge data collected for purposes of the current study assume the perspective of the hospital, and thus do not include charges outside of our hospital or those incurred by the patient and family (i.e., prescription drugs). As our data likely represent an underestimate of health care charges, an important future direction is to assess charges across hospitals, utilizing linked electronic medical records when available. Further, as high deductible health plans become more common, including costs to the families of youth with epilepsy will become even more relevant.
Overall, the results of our study highlight the need for health care teams to routinely monitor HRQOL in pediatric epilepsy care, as it may be used to identify patients who require early intervention, as well as those who might be at-risk for using more health care services and incurring higher charges later in the disease course. Pediatric psychologists are particularly well-suited for this role as they are not only proficient in the assessment of HRQOL but also possess the clinical skills necessary to deliver targeted interventions to improve HRQOL. Use of clinical data from the NOS Clinic and billing data from our hospital was time intensive and complicated to clean and synthesize; however, we encourage pediatric psychologists to use these types of data in their medical clinics, if available, to better understand the impact of behavioral medicine services on both clinical and financial outcomes.
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